Turnstone Biologics Corp IPO Advisory
Share this IPO Profile:Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
| Turnstone Biologics Corp | TSBX - NASDAQ |
$12.00-$14.00 | $12.00 | $11.40 | 6.7 million | 7/21/2023 |
| BofA Securities, SVB Securities, Piper Sandler | ||||||
Co-Manager(s): | ||||||
| Health Care | ||||||
Filing(s): Filed 2023-06-12 Terms Added 2023-07-14 | ||||||
Turnstone Biologics Corp Quote & Chart - Click for current quote - TSBX
IPO Boutique aggregates information on public companies and private companies, such as "TSBX" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
About Turnstone Biologics Corp (adapted from Turnstone Biologics Corp prospectus):
They are a clinical stage biotechnology company focused on developing new medicines to treat and cure patients with solid tumors.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
They are a clinical stage biotechnology company focused on developing new medicines to treat and cure patients with solid tumors.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "TSBX" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.